Click on the links below to view the latest news stories from leading media outlets highlighting ODPRN research and scientists.
Mina Tadrous is a pharmacist and researcher in Toronto who monitors pharmaceutical supplies. He said pharmacists are concerned about drugs such as life-saving inhalers that people might stockpile based on misinformation circulating about potential treatments for COVID-19.
March 27, 2020 | CBC News | News Article
The Royal College of Dental Surgeons of Ontario introduced a new dental opioid prescribing guideline in November 2015. The [ODPRN] examined whether introduction of this guideline was associated with changes in opioid prescribing patterns.
“We assume that these people are friends and family of people who are at risk of an opioid overdose and want to have a naloxone kit on hand in case they are able to intervene to help save that person’s life,” said Dr. Tara Gomes
Patients with overactive bladder who were dispensed mirabegron did not have an increased risk for cardiovascular events compared with other treatments, according to a study published in JAMA Internal Medicine.
Meanwhile, a new report from the Ontario Drug Policy Research Network looked at 1,337 opioid-related deaths in the province from July 2017 to June 2018.
Of the 147,303 publicly funded naloxone kits distributed across the province between July 2017 and June 2018, 8,657 were handed out in the Middlesex-London Health Unit coverage area — a rate of 1,813 per 100,000 people — a new study by the ODPRN says.